Neurocrine
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurocrine and other ETFs, options, and stocks.About NBIX
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids.
CEOKyle W. Gano
CEOKyle W. Gano
Employees1,800
Employees1,800
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1992
Founded1992
Employees1,800
Employees1,800
NBIX Key Statistics
Market cap12.45B
Market cap12.45B
Price-Earnings ratio42.91
Price-Earnings ratio42.91
Dividend yield—
Dividend yield—
Average volume870.88K
Average volume870.88K
High today—
High today—
Low today—
Low today—
Open price$126.48
Open price$126.48
Volume0.00
Volume0.00
52 Week high$157.98
52 Week high$157.98
52 Week low$84.23
52 Week low$84.23
NBIX News
Simply Wall St 4d
Exploring 3 High Growth Tech Stocks In The US MarketAmidst a backdrop of geopolitical tensions and fluctuating oil prices, U.S. markets have shown mixed performance, with key indices like the Dow Jones Industrial...
Simply Wall St 5d
Neurocrine Biosciences Insider Lowered Holding By 28% During Last YearInsiders were net sellers of Neurocrine Biosciences, Inc.'s ( ) stock during the past year. That is, insiders sold more stock than they bought. Although we don...
Analyst ratings
85%
of 27 ratingsBuy
85.2%
Hold
14.8%
Sell
0%
People also own
Based on the portfolios of people who own NBIX. This list is generated using Robinhood data, and it’s not a recommendation.